Search results for

NPR's Scott Detrow talks with labor reporter Josh Eidelson about a report he co-authored in Bloomberg Businessweek about the allegations of sexual harassment at SpaceX and the subsequent lawsuits.

For two astronauts, an eight day mission to the International Space Station has stretched into two months due to vehicle issues. Now, NASA says it's considering bringing them back in a SpaceX capsule.

How did the coconut tree emerge as the emblem of the vice president's most devoted, or at least most-online followers? It's a story more than a year in the making.

There’s no single reason for the slight drop in opioid overdose deaths across most of the U.S. last year. But finding new ways to make Narcan available in public, 24 hours a day, is helping.

The bishops' decision formalizes a yearslong process for the U.S. church to address transgender health care. They also approved a special message on immigration, expressing concern over enforcement and conditions in detention centers.

The presidential campaigns are projecting confidence in Michigan. But the fact that candidates from both major parties are in the state on the same day shows how close the race is in this key state.

Even in a traditionally safe Republican district in Wisconsin, the issue of abortion rights is highlighted, reflecting a larger national debate that is happening about access to abortion this year.

The director of a Chinese-language film festival in New York City says he's been forced to cancel the event because of pressure from the Chinese government on the films' directors.

Homelessness is a pervasive issue that cities across the country struggle to address. This led an entrepreneur to team up with researchers and local foundations for an experiment called the Denver Basic Income Project. What the researchers found could become a guide for how localities in the United States could address the problem of homelessness.

For six of the 10 drugs that Medicare negotiated to lower prices, the net prices aren't any better than the ones insurers already get. But there may be a change in patients' choices of medicines.